RHUMBLINE ADVISERS

Position in CMPX — Compass Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in CMPX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$346,992

-$430,722 QoQ

Shares Held

158,444

+7.8% QoQ

Ownership

0.088%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#73

of 213 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 17% Shared 0% None 83%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. CMPX ranks #210 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$346,992	158,444	+7.8%	Shares	Sole	2026-08-12
2026-03-31	$777,714	147,016	+9.2%	Shares	Sole	2026-05-12
2025-12-31	$722,828	134,605	-3.4%	Shares	Sole	2026-02-13
2025-09-30	$487,595	139,313	+22.8%	Shares	Sole	2025-11-06
2025-06-30	$295,066	113,487	-5.5%	Shares	Sole	2025-08-12
2025-03-31	$228,055	120,029	-7.0%	Shares	Sole	2025-05-29
2024-12-31	$187,218	129,116	+3.1%	Shares	Sole	2025-05-29
2024-09-30	$230,540	125,294	-4.9%	Shares	Sole	2024-11-12
2024-06-30	$131,789	131,789	+10.3%	Shares	Sole	2024-08-01
2024-03-31	$236,558	119,474	+2.5%	Shares	Sole	2024-05-09
2023-12-31	$181,789	116,532	-0.5%	Shares	Sole	2024-02-08
2023-09-30	$230,724	117,119	+4.3%	Shares	Sole	2023-11-09
2023-06-30	$357,203	112,328	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.